Related Articles
Johnson & Johnson abandons deal for Takeda’s TachoSil surgical patch
WASHINGTON (Reuters) – Johnson & Johnson <JNJ.N> said on Friday it abandoned plans to buy Takeda Pharmaceutical’s surgical patch product TachoSil, citing regulatory issues. Takeda <4502.T>, Japan’s biggest drugmaker, announced the sale of TachoSil, a surgical patch to control bleeding, to Johnson & Johnson’s subsidiary Ethicon for $400 million last May. “Ethicon and Takeda have […]
Opinion: China’s leaders are having fun with us. Who can blame them?
OPINION: Anyone who says that China’s President Xi Jinping does not have a sense of humour is definitely not following the news from the Pacific these days. China last week applied for membership in the Trans-Pacific Partnership — the trade deal that was originally negotiated by President Barack Obama precisely to counter China’s economic power […]
Fed policymakers agree rates on hold for ‘a time’
By Jason Lange WASHINGTON (Reuters) – U.S. Federal Reserve policymakers agreed in their final policy meeting of 2019 that interest rates were likely to stay on hold for “a time” as the central bank set its sights on a new articulation of its monetary policy framework. Minutes of the Fed’s Dec. 10-11 policy meeting, released […]